Regulations.gov document
Patent Extension Application from Merck Sharp & Dohme Corp. (on behalf of Peloton…
Other · FDA-2022-E-2095 · posted Aug 31, 2022
Key facts
| Document ID | FDA-2022-E-2095-0002 |
|---|---|
| Title | Patent Extension Application from Merck Sharp & Dohme Corp. (on behalf of Peloton Therapeutics, Inc.) |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2022-E-2095 |
| Posted | Aug 31, 2022 |
| Comment period opens | Aug 31, 2022 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: